|
|
| November 9, 2011: Dr. Dietmar Trenk and Dr. Duane Pinto discuss: TRIGGER-PCI |
Dr. Dietmar Trenk and Dr. Duane Pinto discuss: TRIGGER-PCI: A Prospective, Randomized
Trial of Prasugrel vs. Clopidogrel in Clopidogrel-Hyporesponsive Patients with Stable
Ischemic Heart Disease Undergoing Percutaneous Coronary Intervention
Consulting fees/honoraria: Eli Lilly, Daiichi Sankyo, sanofi-aventis, AstraZeneca
Speaker Honoraria: Eli Lilly, Daiichi Sankyo, sanofi-aventis, AstraZeneca
Off-label use of prasugrel and VerifyNow P2Y12 test will be discussed in this presentation
[ Download video ] |
|
No comments have been submitted
|